{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:34:36Z","timestamp":1787063676777,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.amjms.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:57:48Z","timestamp":1673265468000},"page":"457-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Portal vein thrombosis as the presenting manifestation of JAK2 positive myeloproliferative neoplasm"],"prefix":"10.1016","volume":"365","author":[{"given":"Won Jin","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani Ran","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.amjms.2023.01.002_bib0001","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.amjms.2023.01.002_bib0009","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-0039-1693477","article-title":"Pathogenesis and management of thrombotic disease in myeloproliferative neoplasms","volume":"45","author":"Arachchillage","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.amjms.2023.01.002_bib0002","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archinte.1979.03630430071023","article-title":"Polycythemia vera and mesenteric arterial thrombosis. A disease association resulting from decreased platelet sensitivity to aspirin","volume":"139","author":"Myers","year":"1979","journal-title":"Arch Intern Med"},{"issue":"25","key":"10.1016\/j.amjms.2023.01.002_bib0003","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis","volume":"120","author":"Smalberg","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.amjms.2023.01.002_bib0004","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","article-title":"A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms","volume":"19","author":"Rungjirajittranon","year":"2019","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.amjms.2023.01.002_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41408-018-0100-9","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018","volume":"8","author":"Finazzi","year":"2018","journal-title":"Blood Cancer J"},{"issue":"22","key":"10.1016\/j.amjms.2023.01.002_bib0016","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","article-title":"Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia","volume":"165","author":"Chim","year":"2005","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.amjms.2023.01.002_bib0017","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.amjms.2023.01.002_bib0018","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3324\/haematol.2010.025064","article-title":"Thrombosis in myelofibrosis: prior thrombosis is the only predictive factor and most venous events are provoked","volume":"95","author":"Elliott","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.amjms.2023.01.002_bib0006","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejim.2015.03.009","article-title":"High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms","volume":"26","author":"Enblom","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.amjms.2023.01.002_bib0019","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.7314\/APJCP.2015.16.12.5013","article-title":"Clinical manifestations and risk factors for complications of philadelphia chromosome-negative myeloproliferative neoplasms","volume":"16","author":"Duangnapasatit","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.amjms.2023.01.002_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-016-0242-9","article-title":"Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry","volume":"9","author":"Kaifie","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"11","key":"10.1016\/j.amjms.2023.01.002_bib0021","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1538-7836.2011.04484.x","article-title":"Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms","volume":"9","author":"Hoekstra","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjms.2023.01.002_bib0007","doi-asserted-by":"crossref","first-page":"12367","DOI":"10.2147\/OTT.S287944","article-title":"Impact of mutational profile on the management of myeloproliferative neoplasms: a short review of the emerging data","volume":"13","author":"Loscocco","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"22","key":"10.1016\/j.amjms.2023.01.002_bib0008","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative neoplasms","volume":"376","author":"Spivak","year":"2017","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.amjms.2023.01.002_bib0010","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2023.01.002_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.641613","article-title":"The thrombopoietin receptor, MPL, is a therapeutic target of opportunity in the MPN","volume":"11","author":"Spivak","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.amjms.2023.01.002_bib0012","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am J Hematol"},{"issue":"21","key":"10.1016\/j.amjms.2023.01.002_bib0013","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1001\/jama.2017.2329","article-title":"JAK2 V617F Mutation testing in patients presenting with hepatic and portal vein thrombosis","volume":"317","author":"Foucar","year":"2017","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.amjms.2023.01.002_bib0014","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.2014.117","article-title":"Progressive anemia and left upper quadrant pain in a patient with polycythemia vera","volume":"311","author":"Roberts","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.amjms.2023.01.002_bib0015","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.3390\/cells10123551","article-title":"Progression of myeloproliferative neoplasms (MPN): diagnostic and therapeutic perspectives","volume":"10","author":"Baumeister","year":"2021","journal-title":"Cells"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:42:47Z","timestamp":1757702567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962923000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0002962923000010"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2023.01.002","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portal vein thrombosis as the presenting manifestation of JAK2 positive myeloproliferative neoplasm","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}